Literature DB >> 16636209

Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate.

Michael B Davidson1, John K Hix, Donald G Vidt, Daniel J Brotman.   

Abstract

BACKGROUND: Most healthy people exhibit a decrease in systolic blood pressure (SBP) at night. A drop of less than 10% from mean daytime values (nondipping) is associated with chronic kidney disease, insulin resistance, and cardiovascular events. Whether nondipping precedes a decline in renal function remains unclear. We hypothesized that nondipping would predict a decline in the glomerular filtration rate (GFR) over time.
METHODS: Consecutive patients referred for ambulatory blood pressure monitoring were included in our retrospective cohort if they had a serum creatinine level noted at the time of their ambulatory blood pressure recording and a follow-up creatinine level recorded at least 1 year later. Mean day and night SBPs were compared (nighttime SBP-daytime [corrected] SBP ratio). We defined nondipping as a nighttime [corrected] SBP-daytime [corrected] SBP ratio higher than 0.90. The GFR was calculated using the Modification of Diet in Renal Disease 4-variable equation.
RESULTS: Of 322 patients included, 137 were dippers and 185 were nondippers; their mean baseline GFRs were 80.5 mL/min per 1.73 m(2) and 76.4 mL/min per 1.73 m(2), respectively. During a median follow-up of 3.2 years, the GFRs remained stable among dippers (mean change, 1.3%) but declined among nondippers (mean change, -15.9%) (P<.001). The creatinine levels increased by more than 50% in 2 dippers (1.5%) and in 32 nondippers (17.3%) (P<.001). These findings persisted after adjustment for other predictors of GFR decline.
CONCLUSION: Blunted diurnal blood pressure variation is associated with a subsequent deterioration in renal function that is independent of SBP load and other risk factors for renal impairment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636209     DOI: 10.1001/archinte.166.8.846

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  61 in total

1.  Sleep duration and ambulatory blood pressure in black and white adolescents.

Authors:  Elizabeth J Mezick; Martica Hall; Karen A Matthews
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

Review 2.  Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Juan J Crespo; María T Ríos; Ana Moyá; Francesco Portaluppi
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 3.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 4.  Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Authors:  Lawrence R Krakoff
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

Review 5.  Chronotherapy improves blood pressure control and reduces vascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; Artemio Mojón; José R Fernández; Juan J Crespo; Ana Moyá; María T Ríos; Francesco Portaluppi
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

Review 6.  Recognition and Management of Resistant Hypertension.

Authors:  Branko Braam; Sandra J Taler; Mahboob Rahman; Jennifer A Fillaus; Barbara A Greco; John P Forman; Efrain Reisin; Debbie L Cohen; Mohammad G Saklayen; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 8.237

7.  A prospective cohort study of insomnia and chronic kidney disease in Japanese workers.

Authors:  Sachiko Sasaki; Eiji Yoshioka; Yasuaki Saijo; Akira Bannai; Toshiko Kita; Akiko Tamakoshi; Reiko Kishi
Journal:  Sleep Breath       Date:  2017-05-22       Impact factor: 2.816

Review 8.  Hypertension and chronic kidney disease progression: why the suboptimal outcomes?

Authors:  Anil K Bidani; Karen A Griffin; Murray Epstein
Journal:  Am J Med       Date:  2012-08-17       Impact factor: 4.965

Review 9.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 10.  Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Francesco Portaluppi
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.